We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Decreased expression of USP9X is associated with poor prognosis in Chinese pancreatic ductal adenocarcinoma patients.
- Authors
Liu, Wei; Huo, Yanmiao; Yang, Jianyu; Fu, Xueliang; Yang, Minwei; Tao, Lingye; Liu, Dejun; Zhang, JunfENg; Hua, Rong; Sun, Yongwei
- Abstract
The present study aimed to investigate the expression level of ubiquitin specific peptidase 9X (USP9X) and its clinical significance in Chinese patients with pancreatic ductal adenocarcinoma (PDAC). The mRNA expression levels of USP9X in 30 paired PDAC tissue samples were examined by reverse transcription‑quantitative polymerase chain reaction. The protein expression of USP9X was analyzed by immunohistochemistry (IHC) in a tissue microarray containing 205 PDAC specimens. All analyses were performed by SPSS 20.0 and GraphPad Prism 5.0 software. The USP9X mRNA level was significantly decreased in 18/30 (60.0%) PDAC tissue samples compared with matched surrounding non‑tumor tissue samples. The results of IHC revealed that decreased expression of USP9X was inversely associated with liver metastasis (P=0.032). Kaplan‑Meier survival curves indicated that patients with high expression of USP9X presented a longer clinical overall survival time (P<0.001). Univariate and multivariate COX regression analysis revealed that USP9X protein expression level was a significant, and independent prognostic factor for the overall survival rate of patients with PDAC. The results of the present study indicate that USP9X may serve as a candidate tumor suppressor and prognostic biomarker in PDAC.
- Subjects
PANCREATIC duct; ADENOCARCINOMA; UBIQUITIN; IMMUNOHISTOCHEMISTRY; KAPLAN-Meier estimator; PROGNOSIS; DISEASES
- Publication
Oncology Letters, 2018, Vol 15, Issue 6, p9287
- ISSN
1792-1074
- Publication type
Article
- DOI
10.3892/ol.2018.8452